Amyloid cardiomyopathy
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
| Amyloid cardiomyopathy | |
|---|---|
| Synonyms | Cardiac amyloidosis |
| Pronounce | N/A |
| Specialty | Cardiology |
| Symptoms | Heart failure, arrhythmia, syncope, fatigue |
| Complications | N/A |
| Onset | Typically in adulthood |
| Duration | Chronic |
| Types | N/A |
| Causes | Deposition of amyloid proteins in the heart |
| Risks | Family history, genetic mutations, multiple myeloma |
| Diagnosis | Echocardiogram, cardiac MRI, biopsy |
| Differential diagnosis | Hypertrophic cardiomyopathy, restrictive cardiomyopathy |
| Prevention | N/A |
| Treatment | Chemotherapy, heart transplant, supportive care |
| Medication | N/A |
| Prognosis | Variable, depends on type and stage |
| Frequency | Rare |
| Deaths | N/A |
Amyloid cardiomyopathy is a form of heart disease caused by the deposition of amyloid proteins in the myocardium, the muscular tissue of the heart. This condition is a type of restrictive cardiomyopathy, which is characterized by the stiffening of the heart walls, leading to impaired filling of the heart chambers and reduced cardiac output.
Pathophysiology
Amyloid cardiomyopathy occurs when misfolded amyloid proteins accumulate in the heart tissue. These proteins can be of different types, but the most common in cardiac involvement are light chain amyloidosis (AL amyloidosis) and transthyretin amyloidosis (ATTR amyloidosis). In AL amyloidosis, the amyloid proteins are derived from immunoglobulin light chains, while in ATTR amyloidosis, they are derived from the transthyretin protein. The deposition of amyloid proteins in the myocardium leads to increased stiffness of the heart walls, which impairs diastolic filling and can eventually lead to heart failure. The condition can also affect the electrical conduction system of the heart, leading to arrhythmias.
Clinical Presentation
Patients with amyloid cardiomyopathy may present with symptoms of heart failure, such as dyspnea, fatigue, and edema. Other symptoms may include orthostatic hypotension, syncope, and palpitations. The disease can progress to cause severe heart failure and may be associated with other systemic manifestations of amyloidosis, depending on the type.
Diagnosis
The diagnosis of amyloid cardiomyopathy involves a combination of clinical evaluation, imaging studies, and laboratory tests. Echocardiography is often used to assess cardiac structure and function, revealing thickened ventricular walls and a "sparkling" appearance of the myocardium. Cardiac MRI can provide further detail on tissue characteristics. A definitive diagnosis often requires a biopsy of the heart tissue, demonstrating amyloid deposits. Laboratory tests may include serum and urine protein electrophoresis, immunofixation, and measurement of serum free light chains to identify AL amyloidosis. Genetic testing may be used to identify mutations associated with hereditary ATTR amyloidosis.
Treatment
The treatment of amyloid cardiomyopathy depends on the type of amyloidosis. For AL amyloidosis, treatment focuses on reducing the production of amyloidogenic light chains, often using chemotherapy agents similar to those used in multiple myeloma. For ATTR amyloidosis, treatment may involve the use of transthyretin stabilizers, such as tafamidis, or gene-silencing therapies. Supportive care for heart failure symptoms is also important and may include the use of diuretics, beta-blockers, and other heart failure medications. In some cases, heart transplantation may be considered for eligible patients.
Prognosis
The prognosis of amyloid cardiomyopathy varies depending on the type of amyloidosis and the extent of cardiac involvement. AL amyloidosis generally has a poorer prognosis compared to ATTR amyloidosis, but advances in treatment have improved outcomes for many patients.
See also
Cardiovascular disease A-Z
Most common cardiac diseases
- Cardiac arrhythmia
- Cardiogenetic disorders
- Cardiomegaly
- Cardiomyopathy
- Cardiopulmonary resuscitation
- Chronic rheumatic heart diseases
- Congenital heart defects
- Heart neoplasia
- Ischemic heart diseases
- Pericardial disorders
- Syndromes affecting the heart
- Valvular heart disease
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
A
- Accelerated idioventricular rhythm
- Acute decompensated heart failure
- Arteriosclerotic heart disease
- Athletic heart syndrome
- Atrial flutter
- Atrioventricular fistula
- Cardiovascular disease in Australia
- Autoimmune heart disease
B
C
- Ebb Cade
- Cardiac allograft vasculopathy
- Cardiac amyloidosis
- Cardiac asthma
- Cardiac tamponade
- Cardiogenic shock
- Cardiogeriatrics
- Cardiorenal syndrome
- Cardiotoxicity
- Carditis
- Coronary artery aneurysm
- Coronary artery anomaly
- Coronary artery disease
- Spontaneous coronary artery dissection
- Coronary artery ectasia
- Coronary occlusion
- Coronary steal
- Coronary thrombosis
- Coronary vasospasm
- Cœur en sabot
- Coxsackievirus-induced cardiomyopathy
D
E
H
- Heart attack
- Heart failure
- Heart failure with preserved ejection fraction
- Heart to Heart (1949 film)
- High-output heart failure
- Hyperdynamic precordium
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
I
- Idiopathic giant-cell myocarditis
- Interventricular dyssynchrony
- Intraventricular dyssynchrony
- Isolated atrial amyloidosis
K
L
M
- Mydicar
- Myocardial bridge
- Myocardial disarray
- Myocardial rupture
- Myocardial scarring
- Myocardial stunning
- Myocarditis
N
O
P
- Papillary fibroelastoma
- Pathophysiology of heart failure
- Postpericardiotomy syndrome
- Pulmonary vein stenosis
R
S
- Saturated fat and cardiovascular disease
- SCAR-Fc
- Shone's syndrome
- Strain pattern
- Subacute bacterial endocarditis
- Sudden cardiac death of athletes
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
T
V
W
| Amyloidosis | ||||||
|---|---|---|---|---|---|---|
|
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD